NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS JUL 15 2026 MOLLY C. DWYER, CLERK U.S. COURT OF APPEALS FOR THE NINTH CIRCUIT
GRISELDA BRAMBILA, No. 25-1989
Plaintiff - Appellant, D.C. No. 1:23-cv-03124-LRS v.
FRANK BISIGNANO, Commissioner of MEMORANDUM* Social Security,
Defendant - Appellee.
Appeal from the United States District Court for the Eastern District of Washington Lonny R. Suko, District Judge, Presiding
Argued and Submitted April 24, 2026 Seattle, Washington
Before: W. FLETCHER and KOH, Circuit Judges, and RAYES, District Judge.**
Griselda Brambila appeals from the district court’s order affirming an
Administrative Law Judge’s (ALJ) denial of her application for supplemental
security income under Title XVI of the Social Security Act. We have jurisdiction
* This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3. ** The Honorable Douglas L. Rayes, United States District Judge for the District of Arizona, sitting by designation. under 28 U.S.C. § 1291. We reverse the district court’s decision and remand with
instructions to remand to the ALJ for the calculation and award of benefits.
“The [ALJ’s] disability determination should be upheld unless it contains
legal error or is not supported by substantial evidence.” Orn v. Astrue, 495 F.3d
625, 630 (9th Cir. 2007). Substantial evidence is more than a scintilla, less than a
preponderance, and relevant evidence that a reasonable person might accept as
adequate to support a conclusion considering the whole record. Id.
Brambila contends that the ALJ erred in evaluating various medical source
opinions and assessing the limiting effects of her impairments, including her
migraines and psychogenic non-epileptic seizures (PNES). We conclude that the
ALJ materially erred in assessing Brambila’s migraines and PNES, and that these
errors alone warrant remanding for the calculation and award of benefits. We
therefore do not reach Brambila’s other arguments.
1. The ALJ improperly discounted Brambila’s allegations concerning the
frequency and severity of her migraines. Proper evaluation of a claimant’s
symptom allegations requires the ALJ to perform a two-step analysis. Garrison v.
Colvin, 759 F.3d 995, 1014 (9th Cir. 2014). “First, the ALJ must determine
whether the claimant has presented objective medical evidence of an underlying
impairment which could reasonably be expected to produce the pain or other
symptoms alleged.” Id. (internal quotation marks and citations omitted). If the
2 25-1989 claimant presents such evidence “and there is no evidence of malingering, the ALJ
can reject the claimant’s testimony about the severity of her symptoms only by
offering specific, clear and convincing reasons for doing so.” Id. at 1014–15
(internal quotation marks and citations omitted).
In response to a September 2018 questionnaire, Brambila reported that she
began experiencing migraines following a car accident in 2007. These migraines
caused nausea, vision changes, throbbing pain, and sensitivity to light and sound.
She reported that they occurred about fourteen times per month without
medication, but only two to four times per month with medication, although even
with medication they would last two to four days each. During her first
administrative hearing in June 2020, Brambila testified that she would have
“maybe one [migraine] a month” with medication. During her second
administrative hearing in March 2023, Brambila testified that, when taking
topiramate, she experienced about two migraines per month lasting at least two
days each.
The ALJ found that Brambila’s medically determinable impairments could
reasonably be expected to cause her symptoms and did not find Brambila
malingered. But the ALJ found Brambila’s migraines were not as limiting as she
claimed because of three perceived “inconsistencies in the record.”
3 25-1989 First, the ALJ observed that Brambila worked during the time she reported
experiencing migraines, suggesting they are not as limiting as she describes. This
reason lacks substantial evidentiary support. Brambila’s earning records reflect
little to no income during this period. That Brambila could perform some sporadic,
insubstantial work during this time does not undermine her testimony.
Next, the ALJ noted that Brambila alleges her migraines cause memory
problems, but no memory problems are documented in the medical record.
Although the ALJ provided a sufficiently supported reason for discounting
Brambila’s claim that her migraines caused memory issues, this reason does not
justify discounting Brambila’s testimony that her migraines occurred up to twice a
month and lasted at least two days at a time.
Finally, the ALJ remarked that the treating records “do not document
migraines, or headaches, of the frequency [Brambila] has described.” But the ALJ
did not support this finding with substantial evidence in the record. Instead, the
ALJ isolated two pages of the record to support her conclusion: treatment notes
from Brambila’s visits with her treating neurologist on June 9, 2020, and January
3, 2023, both of which state under the “History of Patient Illness” section that
Brambila was taking topiramate in August 2018, which helped reduce her
headaches to one or two per month of short duration. The ALJ, however, did not
4 25-1989 account for considerable evidence supporting Brambila’s allegations concerning
the frequency and duration of her migraines.
For example, when Brambila began seeing her treating neurologist in
November 2017, she reported experiencing migraines more than fifteen days per
month, with each migraine lasting two to four days. In August 2018, records show
topiramate helped reduce her migraines to one or two mild headaches per month.
The following month, however, Brambila reported that, even with medication, her
migraines were occurring two to four times per month, each lasting for two to four
days. In May 2019, progress notes indicate Brambila was experiencing four
migraines per month even with topiramate, and that she was unhappy with the side
effects of the medication. She had two migraines per month in November 2019,
roughly one per month in 2020 and 2021, and up to two a month in 2022 and 2023.
The totality of the record therefore paints a picture consistent with the thrust of
Brambila’s testimony: her migraines worsened significantly in 2017; at times
topiramate helped reduce their frequency to once or twice per month; but even with
the medication, those monthly migraines could last for at least a day.
The ALJ’s error in assessing Brambila’s testimony concerning the frequency
and duration of her migraines was not harmless because a vocational expert
testified that the “accepted norm within unskilled work” is no more than one
missed day per month and no more than ten percent of the workday off-task.
5 25-1989 Someone experiencing severe migraines as often as Brambila claims would be
unable to sustain a full-time unskilled job.
2. The ALJ did not properly evaluate Brambila’s PNES.1 The ALJ found
that Brambila has a severe non-epileptic, pseudo-seizure disorder. The record
Free access — add to your briefcase to read the full text and ask questions with AI
NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS JUL 15 2026 MOLLY C. DWYER, CLERK U.S. COURT OF APPEALS FOR THE NINTH CIRCUIT
GRISELDA BRAMBILA, No. 25-1989
Plaintiff - Appellant, D.C. No. 1:23-cv-03124-LRS v.
FRANK BISIGNANO, Commissioner of MEMORANDUM* Social Security,
Defendant - Appellee.
Appeal from the United States District Court for the Eastern District of Washington Lonny R. Suko, District Judge, Presiding
Argued and Submitted April 24, 2026 Seattle, Washington
Before: W. FLETCHER and KOH, Circuit Judges, and RAYES, District Judge.**
Griselda Brambila appeals from the district court’s order affirming an
Administrative Law Judge’s (ALJ) denial of her application for supplemental
security income under Title XVI of the Social Security Act. We have jurisdiction
* This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3. ** The Honorable Douglas L. Rayes, United States District Judge for the District of Arizona, sitting by designation. under 28 U.S.C. § 1291. We reverse the district court’s decision and remand with
instructions to remand to the ALJ for the calculation and award of benefits.
“The [ALJ’s] disability determination should be upheld unless it contains
legal error or is not supported by substantial evidence.” Orn v. Astrue, 495 F.3d
625, 630 (9th Cir. 2007). Substantial evidence is more than a scintilla, less than a
preponderance, and relevant evidence that a reasonable person might accept as
adequate to support a conclusion considering the whole record. Id.
Brambila contends that the ALJ erred in evaluating various medical source
opinions and assessing the limiting effects of her impairments, including her
migraines and psychogenic non-epileptic seizures (PNES). We conclude that the
ALJ materially erred in assessing Brambila’s migraines and PNES, and that these
errors alone warrant remanding for the calculation and award of benefits. We
therefore do not reach Brambila’s other arguments.
1. The ALJ improperly discounted Brambila’s allegations concerning the
frequency and severity of her migraines. Proper evaluation of a claimant’s
symptom allegations requires the ALJ to perform a two-step analysis. Garrison v.
Colvin, 759 F.3d 995, 1014 (9th Cir. 2014). “First, the ALJ must determine
whether the claimant has presented objective medical evidence of an underlying
impairment which could reasonably be expected to produce the pain or other
symptoms alleged.” Id. (internal quotation marks and citations omitted). If the
2 25-1989 claimant presents such evidence “and there is no evidence of malingering, the ALJ
can reject the claimant’s testimony about the severity of her symptoms only by
offering specific, clear and convincing reasons for doing so.” Id. at 1014–15
(internal quotation marks and citations omitted).
In response to a September 2018 questionnaire, Brambila reported that she
began experiencing migraines following a car accident in 2007. These migraines
caused nausea, vision changes, throbbing pain, and sensitivity to light and sound.
She reported that they occurred about fourteen times per month without
medication, but only two to four times per month with medication, although even
with medication they would last two to four days each. During her first
administrative hearing in June 2020, Brambila testified that she would have
“maybe one [migraine] a month” with medication. During her second
administrative hearing in March 2023, Brambila testified that, when taking
topiramate, she experienced about two migraines per month lasting at least two
days each.
The ALJ found that Brambila’s medically determinable impairments could
reasonably be expected to cause her symptoms and did not find Brambila
malingered. But the ALJ found Brambila’s migraines were not as limiting as she
claimed because of three perceived “inconsistencies in the record.”
3 25-1989 First, the ALJ observed that Brambila worked during the time she reported
experiencing migraines, suggesting they are not as limiting as she describes. This
reason lacks substantial evidentiary support. Brambila’s earning records reflect
little to no income during this period. That Brambila could perform some sporadic,
insubstantial work during this time does not undermine her testimony.
Next, the ALJ noted that Brambila alleges her migraines cause memory
problems, but no memory problems are documented in the medical record.
Although the ALJ provided a sufficiently supported reason for discounting
Brambila’s claim that her migraines caused memory issues, this reason does not
justify discounting Brambila’s testimony that her migraines occurred up to twice a
month and lasted at least two days at a time.
Finally, the ALJ remarked that the treating records “do not document
migraines, or headaches, of the frequency [Brambila] has described.” But the ALJ
did not support this finding with substantial evidence in the record. Instead, the
ALJ isolated two pages of the record to support her conclusion: treatment notes
from Brambila’s visits with her treating neurologist on June 9, 2020, and January
3, 2023, both of which state under the “History of Patient Illness” section that
Brambila was taking topiramate in August 2018, which helped reduce her
headaches to one or two per month of short duration. The ALJ, however, did not
4 25-1989 account for considerable evidence supporting Brambila’s allegations concerning
the frequency and duration of her migraines.
For example, when Brambila began seeing her treating neurologist in
November 2017, she reported experiencing migraines more than fifteen days per
month, with each migraine lasting two to four days. In August 2018, records show
topiramate helped reduce her migraines to one or two mild headaches per month.
The following month, however, Brambila reported that, even with medication, her
migraines were occurring two to four times per month, each lasting for two to four
days. In May 2019, progress notes indicate Brambila was experiencing four
migraines per month even with topiramate, and that she was unhappy with the side
effects of the medication. She had two migraines per month in November 2019,
roughly one per month in 2020 and 2021, and up to two a month in 2022 and 2023.
The totality of the record therefore paints a picture consistent with the thrust of
Brambila’s testimony: her migraines worsened significantly in 2017; at times
topiramate helped reduce their frequency to once or twice per month; but even with
the medication, those monthly migraines could last for at least a day.
The ALJ’s error in assessing Brambila’s testimony concerning the frequency
and duration of her migraines was not harmless because a vocational expert
testified that the “accepted norm within unskilled work” is no more than one
missed day per month and no more than ten percent of the workday off-task.
5 25-1989 Someone experiencing severe migraines as often as Brambila claims would be
unable to sustain a full-time unskilled job.
2. The ALJ did not properly evaluate Brambila’s PNES.1 The ALJ found
that Brambila has a severe non-epileptic, pseudo-seizure disorder. The record
shows that the frequency of these episodes varies. In January 2020, Brambila
reported having four episodes in a single week. From February 2020 through June
1 At Step 3, the ALJ erroneously stated that “there is no specific listing for pseudo-seizures” and instead considered whether Brambila’s symptoms equaled the criteria for the epilepsy listing, 11.02. Listing 11, however, states that “psychogenic nonepileptic seizures and pseudoseizures are not epileptic seizures for the purpose of 11.02” and “[w]e evaluate psychogenic seizures and pseudoseizures under the mental disorders body system, 12.00.” 20 C.F.R. § 404, Subpt. P, App. 1, 11.00(H)(1). The relevant Listing in 12 is 12.07, and the ALJ never considered whether Brambila’s PNES meets those criteria. Brambila, however, forfeited this argument by not raising it. See Lui v. DeJoy, 129 F.4th 770, 780 (9th Cir. 2025). At any rate, the error was harmless because it “was inconsequential to the ultimate nondisability determination.” Stout v. Comm’r, Soc. Sec. Admin., 454 F.3d 1050, 1055 (9th Cir. 2006). Listing 12.07 requires Brambila to have one “extreme limitation” or two “marked limitations” in the “Paragraph B” criteria. 20 C.F.R. § 404, Subpt. P, App. 1, 12.00(A)(2)(b). Those Paragraph B criteria are identical in the Listings for Depressive & Bipolar Disorder, 12.04; Anxiety, 12.06; Personality Disorder, 12.08; and Trauma and Stressor related disorders, 12.15. Id. At Step 3, the ALJ considered the Paragraph B criteria for all four of these Listings and found that Brambila had only a “moderate limitation” in all four of the Paragraph B criteria, which Brambila does not challenge. Thus, the ALJ’s failure to consider the proper Listing was harmless because the ALJ necessarily found that Brambila could not meet 12.07’s Paragraph B criteria.
6 25-1989 2020, she reported having multiple episodes per day. Records from July 2020,
March 2021, and January 2023 indicate that Brambila experienced multiple
episodes per week. Progress notes from August 2020 describe five different seizure
types: (1) minute-long episodes causing breathing difficulties, shaking, and
stuttering, (2) “[e]pisodes of altered awareness with staring spells, being
unresponsive,” (3) “[c]onvulsive episodes” occurring weekly, lasting for up to
fifteen minutes each, (4) episodes causing a “spinning sensation” and “blurry
vision,” and (5) episodes causing “[i]ntermittent shaking” that can last for a few
minutes and leave her stuttering, weak, confused, and aggressive.
The ALJ did not consider how these episodes affect Brambila’s ability to
work. Instead, the ALJ merely described Brambila’s medical diagnosis—a non-
epileptic, psychogenic disorder unresponsive to epilepsy medications—without
evaluating whether and, if so, to what extent these episodes impact Brambila’s
residual functional capacity.
Aside from describing Brambila’s diagnosis, the ALJ also remarked that
Brambila’s episodes did not cause loss of consciousness, “just stutters.” But this
description ignores the other reported effects of Brambila’s episodes, including
shaking, blurring vision, breathing difficulties, and unresponsiveness.
The ALJ’s failure to consider the effects of Brambila’s PNES is not
harmless because a vocational expert opined that someone performing unskilled
7 25-1989 work would be expected to be off task no more than ten percent of the workday. If
the evidence concerning the frequency, duration, and effects of Brambila’s PNES
episodes were credited, it is hard to see how she could sustain full-time work.
3. Remand for the calculation and award of benefits is appropriate. Though
ordinarily the remedy for a defective nondisability determination is to remand for
further proceedings, “in appropriate circumstances courts are free to reverse and
remand a determination . . . with instructions to calculate and award benefits.”
Garrison, 759 F.3d at 1019. Under our credit-as-true rule, we may remand for a
calculation of benefits if (1) the ALJ failed to provide legally sufficient reasons for
rejecting the evidence at issue, (2) the record has been fully developed and further
administrative proceedings would not be useful, and (3) the ALJ would have to
find the claimant disabled if the improperly discredited evidence were credited. Id.
at 1020. This rule “is designed to achieve fairness and efficiency[.]” Id. at 1019.
The ALJ did not provide sufficient reasons for discounting Brambila’s
allegations concerning her migraines, nor did the ALJ properly consider
Brambila’s PNES. After two separate administrative hearings, we find the record is
fully developed and that further administrative proceedings are unnecessary. See
id. at 1021 (“[T]he objectives of the credit-as-true rule foreclose the argument that
a remand for the purpose of allowing the ALJ to have a mulligan qualifies as a
remand for a useful purpose[.]” (internal quotation marks and citations omitted)).
8 25-1989 Had the ALJ credited Brambila’s allegations concerning the frequency, duration,
and effects of her migraines and accounted for her PNES, the ALJ would have had
to find Brambila disabled because the combined effects of these conditions would
prevent her from maintaining a full-time job due to absenteeism and/or being off
task too much. We therefore reverse the judgment of the district court with
instructions to remand to the ALJ for the calculation and award of benefits.
REVERSED AND REMANDED.
9 25-1989